<SEC-DOCUMENT>0001193125-25-227025.txt : 20251001
<SEC-HEADER>0001193125-25-227025.hdr.sgml : 20251001
<ACCEPTANCE-DATETIME>20251001172333
ACCESSION NUMBER:		0001193125-25-227025
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250930
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251001
DATE AS OF CHANGE:		20251001

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Climb Bio, Inc.
		CENTRAL INDEX KEY:			0001768446
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				832273741
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40708
		FILM NUMBER:		251365642

	BUSINESS ADDRESS:	
		STREET 1:		20 WILLIAM STREET
		STREET 2:		SUITE 145
		CITY:			WELLESLEY HILLS
		STATE:			MA
		ZIP:			02481
		BUSINESS PHONE:		1-866-857-2596

	MAIL ADDRESS:	
		STREET 1:		20 WILLIAM STREET
		STREET 2:		SUITE 145
		CITY:			WELLESLEY HILLS
		STATE:			MA
		ZIP:			02481

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Eliem Therapeutics, Inc.
		DATE OF NAME CHANGE:	20190219
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d33819d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:clym="http://climbbio.com/20250930" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-290">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2025-09-30_to_2025-09-30">0001768446</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="clym-20250930.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-09-30_to_2025-09-30"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001768446</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-30</xbrli:startDate> <xbrli:endDate>2025-09-30</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-301">8-K</ix:nonNumeric></span></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-09-30_to_2025-09-30" format="ixt:datemonthdayyearen" id="ixv-302">September&#160;30, 2025</ix:nonNumeric></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-303">CLIMB BIO, INC.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in its Charter)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2025-09-30_to_2025-09-30" format="ixt-sec:stateprovnameen" id="ixv-304">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-305">001-40708</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-306">83-2273741</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-307">20 William Street</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-308">Suite 145</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-309">Wellesley Hills</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2025-09-30_to_2025-09-30" format="ixt-sec:stateprovnameen" id="ixv-310">Massachusetts</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-311">02481</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, Including Area Code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-312">(866)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-313">857-2596</ix:nonNumeric></span></p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:5pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2025-09-30_to_2025-09-30" format="ixt-sec:boolballotbox" id="ixv-314">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:5pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2025-09-30_to_2025-09-30" format="ixt-sec:boolballotbox" id="ixv-315">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:5pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2025-09-30_to_2025-09-30" format="ixt-sec:boolballotbox" id="ixv-316">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:5pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2025-09-30_to_2025-09-30" format="ixt-sec:boolballotbox" id="ixv-317">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-318">Common Stock, par value $0.0001 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-319">CLYM</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-09-30_to_2025-09-30" format="ixt-sec:exchnameen" id="ixv-320">The Nasdaq Stock Market LLC</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">(The Nasdaq Global Market)</p></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (&#167; <span style="white-space:nowrap">240.12b-2</span> of this chapter).</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2025-09-30_to_2025-09-30" format="ixt-sec:boolballotbox" id="ixv-321">&#9746;</ix:nonNumeric></p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;<ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2025-09-30_to_2025-09-30" format="ixt-sec:boolballotbox" id="ixv-322">&#9744;</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;5.02.</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Appointment of Chief Financial Officer </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&#160;30, 2025, the Board of Directors (the &#8220;Board&#8221;) of Climb Bio, Inc. (the &#8220;Company&#8221;) appointed Susan Altschuller, Ph.D., MBA, as Chief Financial Officer and Treasurer of the Company and designated her as the Company&#8217;s principal financial officer, effective as of October&#160;1, 2025 (the &#8220;Effective Date&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Susan Altschuller, Ph.D., MBA, 44, most recently served as Chief Financial Officer of Dragonfly Therapeutics, Inc., a private biotechnology company, from August 2024 to December 2024. Prior to that, she served as the Chief Financial Officer of Cerevel Therapeutics, Inc. (&#8220;Cerevel&#8221;), a publicly traded clinical-stage biopharmaceutical company, from May 2023 until its acquisition by AbbVie Inc. in August 2024. Prior to joining Cerevel, Dr.&#160;Altschuller was Chief Financial Officer of ImmunoGen, Inc. (&#8220;ImmunoGen&#8221;), a publicly traded biopharmaceutical company, from July 2020 to March 2023. Before ImmunoGen, Dr.&#160;Altschuller worked at Alexion Pharmaceuticals, Inc., a global biopharmaceutical company, where she served as Head of Enterprise Finance from April 2020 to July 2020 and Head of Investor Relations from January 2018 to April 2020. From February 2017 to January 2018, Dr.&#160;Altschuller was Head of Investor Relations at Bioverativ Inc., a multinational biotechnology company created from a separation of Biogen Inc.&#8217;s (&#8220;Biogen&#8221;) global hemophilia business. Early in her career, Dr.&#160;Altschuller held positions at Biogen in various functions of increasing responsibility, including investor relations, corporate finance, and commercial finance. Dr.&#160;Altschuller holds a BSE in Biomedical Engineering with honors from Tulane University, a Ph.D. in biomedical engineering from the Illinois Institute of Technology, and an MBA from the MIT Sloan School of Management. She previously served as a director of Mural Oncology plc from November 2023 to September 2024, and is a founding board member of the HNRNP Family Foundation. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to an offer letter (the &#8220;Offer Letter&#8221;), dated September&#160;30, 2025, between the Company and Dr.&#160;Altschuller governing the terms of her employment, Dr.&#160;Altschuller will be paid a base salary of $510,000 per year. Dr.&#160;Altschuller will also be eligible to receive an annual discretionary bonus of up to 40% of her annualized base salary each year, as determined by the Board in its sole discretion. Also, as a condition to her employment and pursuant to the Offer Letter, Dr.&#160;Altschuller will enter into a confidential information, inventions assignment, <span style="white-space:nowrap">non-competition</span> and <span style="white-space:nowrap">non-solicitation</span> agreement with the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Effective as of the Effective Date, the Board granted to Dr.&#160;Altschuller a stock option to purchase 600,000 shares of the Company&#8217;s common stock (the &#8220;Common Stock&#8221;) at an exercise price per share equal to the closing price of the Common Stock on The Nasdaq Global Market on the Effective Date (the &#8220;Option&#8221;). The Option was granted pursuant to the Company&#8217;s 2025 Inducement Plan, as amended, and will vest as to 25% of the shares underlying the Option on the first anniversary of the Effective Date and in 36 equal monthly installments thereafter, subject to Dr.&#160;Altschuller&#8217;s continued service. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the Offer Letter provides that Dr.&#160;Altschuller will be eligible to participate in benefits plans offered to similarly-situated employees by the Company, subject to plan terms and generally applicable Company policies. In the event that the Company terminates Dr.&#160;Altschuller&#8217;s employment without cause (as defined in the Offer Letter) or Dr.&#160;Altschuller resigns for good reason (as defined in the Offer Letter) at any time that is not during the three months prior to, as of, or within twelve months following the effective date of a change in control (as defined in the Offer Letter) and subject to the satisfaction of certain conditions, including Dr.&#160;Altschuller&#8217;s execution of a separation agreement containing an effective, general release of claims in favor of the Company, the Company will be obligated to (1) (a) in the case where Dr.&#160;Altschuller has been employed with the Company for at least 12 months, pay to Dr.&#160;Altschuller in a single lump sum an amount equal to nine months of her then current base salary and the amount of her target annual discretionary bonus opportunity for the year in which the termination of her employment occurs (the &#8220;Target Amount&#8221;), or (b)&#160;in the case where Dr.&#160;Altschuller has been employed with the Company for less than 12 months, pay to Dr.&#160;Altschuller in a single lump sum an amount equal to four months of her then current base salary and the Target Amount, (2)&#160;make payments for the continuation of Dr.&#160;Altschuller&#8217;s health coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;COBRA&#8221;) for a period of (a)&#160;in the case where Dr.&#160;Altschuller has been employed with the Company for at least 12 months, up to </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
nine months, or (b)&#160;in the case where Dr.&#160;Altschuller has been employed with the Company for less than 12 months, up to four months, and (3)&#160;accelerate the vesting and exercisability of any outstanding and unvested equity awards subject to time-based or service-based vesting that are held by Dr.&#160;Altschuller as of immediately prior to her termination of employment and that are scheduled to vest and become exercisable in the three month period immediately following Dr.&#160;Altschuller&#8217;s termination of employment. Alternatively, if the Company terminates Dr.&#160;Altschuller&#8217;s employment without cause or Dr.&#160;Altschuller resigns for good reason during the three months prior to, as of, or within 12 months following the effective date of a change in control, and subject to the satisfaction of certain conditions, including Dr.&#160;Altschuller&#8217;s execution of a separation agreement containing an effective, general release of claims in favor of the Company, the Company will be obligated to (1)&#160;pay to Dr.&#160;Altschuller in a single lump sum an amount equal to 12 months of her then current base salary, the Target Amount and any annual bonus for the previous calendar year that has not yet been paid, (2)&#160;make payments for the continuation of Dr.&#160;Altschuller&#8217;s health coverage under COBRA for a period of up to 12 months and (3)&#160;accelerate the vesting and exercisability of all outstanding and unvested equity awards subject to time-based or service-based vesting that are held by Dr.&#160;Altschuller as of immediately prior to her termination of employment. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, Dr.&#160;Altschuller will enter into an indemnification agreement with the Company, the form of which was filed as Exhibit 10.8 to the Company&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-1</span> (File <span style="white-space:nowrap">No.&#160;333-257980)</span> filed with the SEC on August&#160;2, 2021, pursuant to which the Company may be required, among other things, to indemnify Dr.&#160;Altschuller for certain expenses (including attorneys&#8217; fees), judgments, penalties, fines and amounts paid in settlement actually and reasonably incurred by Dr.&#160;Altschuller in any action or proceeding arising out of her service to and activities on behalf of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is no arrangement or understanding between Dr.&#160;Altschuller and any other person pursuant to which Dr.&#160;Altschuller was appointed as Chief Financial Officer of the Company. There are no related party transactions between the Company and Dr.&#160;Altschuller reportable under Item 404(a) of Regulation <span style="white-space:nowrap">S-K</span> and no family relationships between Dr.&#160;Altschuller and any of the Company&#8217;s directors or officers. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the Offer Letter does not purport to be complete and is qualified in its entirety by the full text of the Offer Letter, a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result of Dr.&#160;Altschuller&#8217;s designation as principal financial officer, Cindy Driscoll, the Company&#8217;s Senior Vice President, Finance, ceased to serve as the Company&#8217;s principal financial officer, effective as of the Effective Date. Ms.&#160;Driscoll continues to serve as the Company&#8217;s principal accounting officer. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Amendment to Inducement Plan </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&#160;30, 2025, the Board, upon the recommendation of the Compensation Committee of the Board, approved an amendment to the Company&#8217;s 2025 Inducement Plan (the &#8220;Inducement Plan&#8221;) to increase the number of shares of common stock, par value $0.0001 per share, of the Company (the &#8220;Common Stock&#8221;) reserved for issuance under the Inducement Plan from 1,250,000 shares of Common Stock to 2,000,000 shares of Common Stock. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;9.01.</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Exhibit<br/>No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d33819dex101.htm">Offer Letter, dated September&#160;30, 2025, between Climb Bio, Inc. and Susan Altschuller, Ph.D., MBA </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (formatted as Inline XBRL)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">Climb Bio, Inc.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: October&#160;1, 2025</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">/s/ Aoife Brennan</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">Aoife Brennan, M.B., Ch.B.</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">President and Chief Executive Officer</span></td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d33819dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g33819g1002000749355.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September&nbsp;30, 2025 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Susan Altschuller </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Via email to [**] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Re: Offer of Employment </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Susan, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are very pleased to offer you employment with Climb Bio, Inc. (the &#8220;<B><I>Company</I></B>&#8221;), effective October&nbsp;1, 2025 (the
&#8220;<B><I>Start Date</I></B>&#8221;). The initial terms of your employment with the Company are as set forth in this offer letter agreement (the &#8220;<B><I>Agreement</I></B>&#8221;). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Position </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your initial position will be Chief Financial
Officer, and you shall be responsible for performing such duties as are assigned to you from time to time consistent with duties typically associated with that position, reporting to the Company&#8217;s Chief Executive Officer. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Company&nbsp;&amp; Work Location </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s
headquarters are in Wellesley, MA. As part of your employment with the Company you will be expected to work <FONT STYLE="white-space:nowrap">on-site</FONT> at least 3 days a week and as may be required by your duties and responsibilities. The
Company reserves the right to revise its practices and requirements related to <FONT STYLE="white-space:nowrap">on-site</FONT> work. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation and
Benefits </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your base salary will be at the annualized rate of $510,000 less payroll deductions and withholdings, paid on the Company&#8217;s normal
payroll schedule (&#8220;<B><I>Base Salary</I></B>&#8221;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following the end of each calendar year, you will be eligible to receive an annual
discretionary bonus (the &#8220;<B><I>Annual Bonus</I></B>&#8221;) with an annual target of forty percent (40%) of the base salary you actually received during the applicable bonus year (the &#8220;<B><I>Target Amount</I></B>&#8221;). The amount of
the Annual Bonus will be determined in the sole discretion of the Company&#8217;s Board of Directors (the &#8220;<B><I>Board</I></B>&#8221;), or a committee thereof, and based, in part, on your performance and the performance of the Company during
the applicable bonus year, as well as any other criteria the Board, or a committee thereof, deems relevant, and will be paid less payroll deductions and withholdings. You must be an active employee of the Company on the date any Annual Bonus is paid
in order to be eligible for and to earn any bonus award, as it also serves as an incentive for you to remain employed with the Company, and no portion of the Annual Bonus will be paid to you if your employment terminates for any reason prior to the
payment date. If you commence employment between February&nbsp;1 and October&nbsp;1 of a calendar year, your bonus will be <FONT STYLE="white-space:nowrap">pro-rated</FONT> for that calendar year. If you commence employment after October&nbsp;1 of a
calendar year, you will not receive a bonus for that calendar year. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g33819g1002000749355.jpg" ALT="LOGO" STYLE="width:2.02917in;height:0.423611in;">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will be eligible to accrue and use up to 20 days&#8217; paid vacation during each calendar year, subject
to applicable Company policies. In addition, you will be eligible to take the Company&#8217;s observed holidays in each calendar year, pursuant to Company policies. You may use vacation days in advance of accruing them (i.e., incur a negative
vacation balance), subject to approval by your manager of the specific days you wish to take as vacation, as provided under applicable Company policies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During your employment, you may participate in the benefits plans offered to similarly-situated employees by the Company from time to time, subject to plan
terms (including eligibility terms) and generally applicable Company policies. A full description of current benefits is available for your review. The Company may change benefits from time to time in its sole discretion. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Equity </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a material inducement to your commencing
employment with the Company, subject to approval by the Board or a committee thereof, the Company anticipates granting you, on or following the Start Date, an option to purchase 600,000 shares of the Company&#8217;s common stock with an exercise
price equal to the fair market value of the Company&#8217;s common stock as determined by the Board or a committee thereof as of the date of grant (the &#8220;<B><I>Option</I></B>&#8221;). The anticipated Option is expected to be issued under the
Company&#8217;s 2025 Inducement Plan (the &#8220;<B><I>Plan</I></B>&#8221;), and a grant agreement issued thereunder, and will be issued as an &#8220;inducement grant&#8221; within the meaning of Nasdaq Listing Rule 5635(c)(4), which will be a <FONT
STYLE="white-space:nowrap">non-qualified</FONT> stock option for United States tax purposes. The anticipated Option will have the following vesting schedule: 12/48ths of the total shares will vest on the one year anniversary of the vesting
commencement date set forth in the grant agreement (or if there is no corresponding day, on the last day of the calendar month in which the one year anniversary would otherwise occur), and 1/48th of the total shares will vest each month thereafter
on the same day of the month as the vesting commencement date (or if there is no corresponding day, on the last day of the month), subject to your Continuous Service (as defined in the Plan) as of each such date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will be eligible for future annual equity grants at the discretion of the Board and based on your performance and other criteria that the Board deems
relevant. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Company Policies, Confidential Information and Continuing Obligations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a Company employee, you will be expected to abide by Company rules and policies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, and as a condition of your continued employment with the Company following the Start Date, you will be required to execute, and hereby represent
and agree that you will execute, no earlier than the Start Date but no later than ten (10)&nbsp;business days following the Start Date, an Employee Confidential Information, Inventions Assignment,
<FONT STYLE="white-space:nowrap">Non-Competition,</FONT> and <FONT STYLE="white-space:nowrap">Non-Solicitation</FONT> Agreement in the form enclosed herewith (the &#8220;<B><I>Confidential Information Agreement</I></B>&#8221;), which prohibits
unauthorized use or disclosure of the Company&#8217;s proprietary information, among other obligations (including <FONT STYLE="white-space:nowrap">non-competition</FONT> and <FONT STYLE="white-space:nowrap">non-solicitation</FONT> obligations). You
acknowledge that your eligibility to receive the Option is, as set forth in the Confidential Information Agreement, contingent upon your agreement to the <FONT STYLE="white-space:nowrap">non-competition</FONT> provision set forth in the Confidential
Information Agreement. You further acknowledge that such consideration was mutually agreed upon by you and the Company and is fair and reasonable in exchange for your compliance with such <FONT STYLE="white-space:nowrap">non-competition</FONT>
obligation. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g33819g1002000749355.jpg" ALT="LOGO" STYLE="width:2.02917in;height:0.423611in;">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By signing this Agreement you are representing that you have full authority to accept this position and
perform the duties of the position without conflict with any other obligations and that you are not involved in any situation that might create, or appear to create, a conflict of interest with respect to your loyalty or duties to the Company. You
specifically warrant that you are not subject to an employment agreement or restrictive covenant preventing full performance of your duties to the Company. You agree not to bring to the Company or use in the performance of your responsibilities at
the Company any materials or documents of a former employer that are not generally available to the public, unless you have obtained express written authorization from the former employer for their possession and use. You also agree to honor all
obligations to former employers during your employment with the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">At-Will</FONT> Employment and Exempt Status
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your employment with the Company will be <FONT STYLE="white-space:nowrap">&#8220;at-will.&#8221;</FONT> You may terminate your employment with the
Company at any time and for any reason whatsoever simply by notifying the Company. Likewise, the Company may terminate your employment at any time, with or without Cause or advance notice. Your employment
<FONT STYLE="white-space:nowrap">at-will</FONT> status can only be modified in a written agreement signed by you and by an officer of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As an
exempt salaried employee, you will be expected to work the Company&#8217;s normal business hours as well as additional hours as required by the nature of your work assignments, and you will not be eligible for overtime compensation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Termination by the Company without Cause or Your Resignation for Good Reason Not in Connection with a Change in Control </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event that the Company terminates your employment without Cause (as defined in <B>Exhibit A</B> hereto) or you resign for Good Reason (as defined on
<B>Exhibit A</B> hereto) at any time that is not during the three (3)&nbsp;months prior to, as of, or within twelve (12)&nbsp;months following the effective date of a Change in Control (as defined on <B>Exhibit B </B>hereto), you shall be entitled
to the Accrued Obligations (as defined on <B>Exhibit A</B> hereto) and, subject to your satisfaction of the Conditions (as defined below), you will be eligible for the severance benefits set forth in either (1)&nbsp;or (2) below (as applicable, the
&#8220;<B><I>Non-Change in Control Severance Benefits</I></B>&#8221;<B><I>)</I></B>: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>1.</B> If you have been employed with the Company
for at least 12 months as of your termination date: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>1.1</B> The Company will pay you an amount equal to the sum of (x)&nbsp;nine (9)
months of your then current Base Salary as of your termination date and (y)&nbsp;the Target Amount for the year in which your termination of employment occurs, less all applicable withholdings and deductions, paid in a single lump sum on the
Company&#8217;s first regularly scheduled payroll date that is at least one week after the Release Effective Date (as defined below). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g33819g1002000749355.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>1.2 </B>Provided you timely elect continued coverage under COBRA under the Company&#8217;s
group health plans following such termination, the Company will pay your COBRA premiums to continue your health insurance coverage in effect on the employment termination date until the earliest of: (x) nine (9) months following the termination
date; (y) the date when you become eligible for substantially equivalent health insurance coverage in connection with new employment; and (z)&nbsp;the date you cease to be eligible for COBRA continuation coverage for any reason, including plan
termination. Notwithstanding the foregoing, if at any time the Company determines that its payment of COBRA premiums on your behalf would result in a violation of applicable law (including, but not limited to, the 2010 Patient Protection and
Affordable Care Act, as amended by the 2010 Health Care and Education Reconciliation Act), then this benefit shall not apply. Nothing in this Agreement shall deprive you of your rights under COBRA or ERISA for benefits under plans and policies
arising under your employment by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>1.3</B> Effective as of the Release Effective Date, the vesting and exercisability of
any outstanding unvested Company equity awards that are held by you as of immediately prior to your termination of employment and are scheduled to vest and become exercisable under a time-based or service-based schedule in the three (3)&nbsp;month
period immediately following such termination of employment shall be deemed immediately vested and exercisable as of your termination of employment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>2.</B> If you have been employed with the Company for less than 12 months as of your termination date: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>2.1</B> The Company will pay you an amount equal to the sum of (x)&nbsp;four (4) months of your then current Base Salary as of your
termination date and (y)&nbsp;the Target Amount for the year in which your termination of employment occurs, less all applicable withholdings and deductions, paid in a single lump sum on the Company&#8217;s first regularly scheduled payroll date
that is at least one week after the Release Effective Date (as defined below). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>2.2</B> Provided you timely elect continued coverage
under COBRA under the Company&#8217;s group health plans following such termination, the Company will pay your COBRA premiums to continue your health insurance coverage in effect on the employment termination date until the earliest of:
(x)&nbsp;four (4) months following the termination date; (y)&nbsp;the date when you become eligible for substantially equivalent health insurance coverage in connection with new employment; and (z)&nbsp;the date you cease to be eligible for COBRA
continuation coverage for any reason, including plan termination. Notwithstanding the foregoing, if at any time the Company determines that its payment of COBRA premiums on your behalf would result in a violation of applicable law (including, but
not limited to, the 2010 Patient Protection and Affordable Care Act, as amended by the 2010 Health Care and Education Reconciliation Act), then this benefit shall not apply. Nothing in this Agreement shall deprive you of your rights under COBRA or
ERISA for benefits under plans and policies arising under your employment by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>2.3</B> Effective as of the Release
Effective Date, the vesting and exercisability of any outstanding unvested Company equity awards that are held by you as of immediately prior to your termination of employment and are scheduled to vest and become exercisable under a time-based or
service-based schedule in the three (3)&nbsp;month period immediately following such termination of employment shall be deemed immediately vested and exercisable as of your termination of employment. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g33819g1002000749355.jpg" ALT="LOGO" STYLE="width:2.02917in;height:0.423611in;">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Termination by the Company without Cause or Your Resignation for Good Reason in Connection with a Change
in Control </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event that the Company terminates your employment without Cause or you resign for Good Reason during the three (3)&nbsp;months prior
to, as of, or within twelve (12)&nbsp;months following the effective date of a Change in Control (&#8220;<B><I>Change in Control Termination Date</I></B>&#8221;), you shall be entitled to the Accrued Obligations and, subject to your satisfaction of
the Conditions, you will be eligible for the following as your sole severance benefits (the &#8220;<B><I>Change in Control Severance Benefits</I></B>&#8221;<B><I>)</I></B>: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> The Company will pay you an amount equal to the sum of (x)&nbsp;twelve (12) months of your then current Base Salary
and (y)&nbsp;the Target Amount for the year in which your termination of employment occurs and (z)&nbsp;any Annual Bonus for the previous calendar year that has not yet been paid to you, less all applicable withholdings and deductions, paid in a
single lump sum on the Company&#8217;s first regularly scheduled payroll date that is at least one week after the Release Effective Date, or, if later the effective date of a Change in Control. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> Provided you timely elect continued coverage under COBRA under the Company&#8217;s group health plans following
such termination, the Company will pay your COBRA premiums to continue your health insurance coverage in effect on the employment termination date until the earliest of: (x)&nbsp;twelve (12) months following the termination date; (y)&nbsp;the date
when you become eligible for substantially equivalent health insurance coverage in connection with new employment and (z)&nbsp;the date you cease to be eligible for COBRA continuation coverage for any reason, including plan termination.
Notwithstanding the foregoing, if at any time the Company determines that its payment of COBRA premiums on your behalf would result in a violation of applicable law (including, but not limited to, the 2010 Patient Protection and Affordable Care Act,
as amended by the 2010 Health Care and Education Reconciliation Act), then this benefit shall not apply. Nothing in this Agreement shall deprive you of your rights under COBRA or ERISA for benefits under plans and policies arising under your
employment by the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> Effective as of the later of the Release Effective Date and immediately prior to a
Change in Control, the vesting and exercisability of all outstanding unvested Company equity awards that are held by you as of immediately prior to the Change in Control Termination Date and are scheduled to vest and become exercisable under a
time-based or service-based schedule shall be deemed immediately vested and exercisable as of your termination of employment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt,
under no circumstances will you be entitled to receive both the <FONT STYLE="white-space:nowrap">Non-Change</FONT> in Control Severance Benefits and the Change in Control Severance Benefits. In addition, if your employment is terminated by the
Company without Cause or by you for Good Reason prior to a Change in Control, (i)&nbsp;any then-outstanding and unvested equity awards that vest and become exercisable under a time-based or service-based schedule held by you (after taking into
account any <FONT STYLE="white-space:nowrap">Non-Change</FONT> in Control Severance Benefit vesting acceleration provided for above) shall remain outstanding (but any vesting shall be suspended) for up to (but not longer than) three (3)&nbsp;months
following the date of termination so that, if it is later determined that such termination occurred during the three-month period prior to the closing of a Change in Control and you are entitled to Change in Control Severance Benefits rather than <FONT
STYLE="white-space:nowrap">Non-Change</FONT> in Control Severance Benefits, the vesting of such awards may be accelerated immediately prior to the Change in Control and (ii)&nbsp;any Change in Control Severance Benefits shall be reduced by any <FONT
STYLE="white-space:nowrap">Non-Change</FONT> in Control Severance Benefits previously paid to you, if it is later determined that the termination occurred during the three-month period prior to the closing of a Change in Control and that you are
entitled to Change in Control Severance Benefits rather than <FONT STYLE="white-space:nowrap">Non-Change</FONT> in Control Severance Benefits. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g33819g1002000749355.jpg" ALT="LOGO" STYLE="width:2.02917in;height:0.423611in;">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Change in Control</I></B>&#8221; is defined at <B>Exhibit B</B>, which supersedes any other
definitions of Change in Control for all purposes related to your employment with the Company, including but not limited to equity incentive grants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your
receipt of the <FONT STYLE="white-space:nowrap">Non-Change</FONT> in Control Severance Benefits or Change in Control Severance Benefits will be conditioned upon your satisfaction of each of the following conditions (the
&#8220;<B><I>Conditions</I></B>&#8221;): (i) within the timeframe provided by the Company, which shall be no later than the 60th day following the date of your termination of employment, you must have signed and delivered to the Company, in the form
to be provided by the Company at or around the time on which the termination of your employment occurs, a separation agreement containing an effective, general release of claims in favor of the Company and its affiliates and representatives, a
reaffirmation of your continuing obligations under the Confidential Information Agreement, and an agreement not to compete with the Company for twelve (12)&nbsp;months following the date of your termination of employment (the
&#8220;<B><I>Release</I></B>&#8221;), which must not be revoked (the date that the Release can no longer be revoked is referred to as the &#8220;<B><I>Release Effective Date</I></B>&#8221;); (ii) if you hold any other positions with the Company or
any Affiliate, including a position on the Board, you must resign such position(s) to be effective no later than the date of your employment termination (or such other date as requested by the Board); (iii) you must return all Company property;
(iv)&nbsp;you must comply with, and have been in compliance with, all of your obligations under this Agreement and the Confidential Information Agreement; and (v)&nbsp;you must comply with the terms of the Release, including without limitation any <FONT
STYLE="white-space:nowrap">non-disparagement,</FONT> <FONT STYLE="white-space:nowrap">non-competition</FONT> and confidentiality provisions contained in the Release. To the extent that any severance payments are deferred compensation under
Section&nbsp;409A of the Code, and are not otherwise exempt from the application of such Section&nbsp;409A, then, if the 60<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day of the period during which you may consider and sign the Release
spans two calendar years, the payment of any severance will not be made or begin until the later calendar year. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;409A </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary in this Agreement, the following provisions apply to the extent severance benefits provided herein are subject to
Section&nbsp;409A of the Code and the regulations and other guidance thereunder and any state law of similar effect (collectively &#8220;<B><I>Section</I></B><B><I></I></B><B><I>&nbsp;409A</I></B>&#8221;). Severance shall not commence until you have
a &#8220;separation from service&#8221; (as defined under Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(h),</FONT> without regard to any alternative definition thereunder, a &#8220;separation from service&#8221;). Each
installment of severance is a separate &#8220;payment&#8221; for purposes of Treas. Reg. <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-2(b)(2)(i),</FONT> and the severance is intended to satisfy the exemptions from application of
Section&nbsp;409A provided under Treasury Regulations Sections <FONT STYLE="white-space:nowrap">1.409A-1(b)(4),</FONT> <FONT STYLE="white-space:nowrap">1.409A-1(b)(5)</FONT> and <FONT STYLE="white-space:nowrap">1.409A-1(b)(9).</FONT> However, if
such exemptions are not available and you are, upon separation from service, a &#8220;specified employee&#8221; for purposes of Section&nbsp;409A, then, solely to the extent necessary to avoid adverse personal tax consequences under
Section&nbsp;409A, the timing of the severance payments shall be delayed until the earlier of (i)&nbsp;six (6) months and one day after your separation from service, or (ii)&nbsp;as soon as practicable following your death, as may be permitted or
required under Section&nbsp;409A. The parties acknowledge that the exemptions from application of Section&nbsp;409A to severance benefits are fact specific, and any later amendment of this Agreement to alter the timing, amount or conditions that
will trigger payment of severance benefits may preclude the ability of severance benefits provided under this agreement to qualify for an exemption. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g33819g1002000749355.jpg" ALT="LOGO" STYLE="width:2.02917in;height:0.423611in;">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">It is intended that this Agreement shall comply with, or be exempt from, the requirements of
Section&nbsp;409A, and any ambiguity contained herein shall be interpreted in such manner so as to avoid adverse personal tax consequences under Section&nbsp;409A. Notwithstanding the foregoing, the Company does not guarantee that this Agreement so
complies or is so exempt and the Company shall in no event be obligated to indemnify you for any taxes or interest that may be assessed by the Internal Revenue Service pursuant to Section&nbsp;409A of the Code to payments made pursuant to this
Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;280G </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding
anything to the contrary contained in this Agreement, to the extent that any of the payments and benefits provided for under this Agreement or any other agreement or arrangement between you and the Company (collectively, the
&#8220;<B><I>Payments</I></B>&#8221;) constitute a &#8220;parachute payment&#8221; within the meaning of Section&nbsp;280G of the Code and, but for this paragraph, would be subject to the excise tax imposed by Section&nbsp;4999 of the Code, then the
Payments shall be payable either (i)&nbsp;in full or (ii)&nbsp;as to such lesser amount which would result in no portion of such Payments being subject to excise tax under Section&nbsp;4999 of the Code; whichever of the foregoing amounts, taking
into account the applicable federal, state and local income taxes and the excise tax imposed by Section&nbsp;4999 of the Code, results in your receipt on an <FONT STYLE="white-space:nowrap">after-tax</FONT> basis, of the greatest amount of economic
benefits under this Agreement, notwithstanding that all or some portion of such benefits may be taxable under Section&nbsp;4999 of the Code. Unless you and the Company otherwise agree in writing, any determination required under this paragraph shall
be made in writing by the Company&#8217;s independent public accountants or its law firm (the &#8220;<B><I>Analysis Preparers</I></B>&#8221;), whose reasonable determination shall be conclusive and binding upon you and the Company for all purposes.
For purposes of making the calculations required by this paragraph, the Analysis Preparers may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the
application of the Sections 280G and 4999 of the Code. You and the Company shall furnish to the Analysis Preparers such information and documents as the Accountants may reasonably request in order to make a determination under this paragraph. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conditions, Dispute Resolution, and Complete Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This offer is contingent upon a satisfactory reference check, satisfactory proof of your right to work in the United States and satisfactory clearance of a
background check. You agree to assist as needed and to complete any documentation at the Company&#8217;s request to meet these conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To ensure the
timely and economical resolution of disputes that may arise in connection with your employment with the Company, you and the Company agree that any and all disputes, claims, or causes of action, in law or equity, including but not limited to
statutory claims, arising from or relating to the enforcement, breach, performance, or interpretation of this Agreement, your employment with the Company, or the termination of your employment, shall be resolved pursuant to the Federal Arbitration
Act, 9 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1-16,</FONT> to the fullest extent permitted by law, by final, binding and confidential arbitration conducted by JAMS, Inc. or its successor (&#8220;<B><I>JAMS</I></B>&#8221;), under JAMS&#8217;
then applicable rules and procedures appropriate to the relief being sought (available upon request and also currently available at http://www.jamsadr.com/rules-employment-arbitration/). <B>You acknowledge that by agreeing to this arbitration
procedure, both you and the Company waive the right to resolve any such dispute through a trial by jury or judge or administrative proceeding.</B> In addition, all claims, disputes, or causes of action under this paragraph, whether by you or the
Company, must be brought in an individual capacity, and shall not be brought as a plaintiff (or claimant) or class member in any purported class or representative proceeding, nor joined or consolidated with the claims of any other person or entity.
The arbitrator may not </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g33819g1002000749355.jpg" ALT="LOGO" STYLE="width:2.02917in;height:0.423611in;">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
consolidate the claims of more than one person or entity, and may not preside over any form of representative or class proceeding. To the extent that the preceding sentences regarding class
claims or proceedings are found to violate applicable law or are otherwise found unenforceable, any claim(s) alleged or brought on behalf of a class shall proceed in a court of law rather than by arbitration. This paragraph shall not apply to any
action or claim that cannot be subject to mandatory arbitration as a matter of applicable law(s), to the extent any such applicable law(s) are not preempted by the Federal Arbitration Act or otherwise invalid (collectively, the &#8220;<B><I>Excluded
Claims</I></B>&#8221;).&nbsp;In the event you intend to bring multiple claims, including one of the Excluded Claims listed above, the Excluded Claims may be filed with a court, while any other claims will remain subject to mandatory arbitration. You
will have the right to be represented by legal counsel at any arbitration proceeding. Questions of whether a claim is subject to arbitration under this Agreement shall be decided by the arbitrator. Likewise, procedural questions which grow out of
the dispute and bear on the final disposition are also matters for the arbitrator. The arbitrator shall: (a)&nbsp;have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be
permitted by law; and (b)&nbsp;issue a written statement signed by the arbitrator regarding the disposition of each claim and the relief, if any, awarded as to each claim, the reasons for the award, and the arbitrator&#8217;s essential findings and
conclusions on which the award is based. The arbitrator shall be authorized to award all relief that you or the Company would be entitled to seek in a court of law. You and the Company shall equally share all JAMS arbitration fees, or such fees
shall be paid in such other manner to the extent required by, and in accordance with, applicable law to effectuate your and the Company&#8217;s agreement to arbitrate.&nbsp;Each party is responsible for its own attorneys&#8217; fees. Nothing in this
Agreement is intended to prevent either you or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration. Any awards or orders in such arbitrations may be entered and enforced as
judgments in the federal and state courts of any competent jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Agreement forms the complete and exclusive statement of the terms of your
employment with the Company. It supersedes any other agreements or promises made to you by anyone, whether oral or written. If any provision of this Agreement (including, without limitation, the arbitration agreement set forth herein) is determined
to be invalid or unenforceable, in whole or in part, this determination shall not affect any other provision of this Agreement and the provision in question shall be modified so as to be rendered enforceable in a manner consistent with the intent of
the parties insofar as possible under applicable law. This Agreement may be delivered and executed via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic
Transactions Act or other applicable law) or other transmission method and shall be deemed to have been duly and validly delivered and executed and be valid and effective for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">* &#8195;&#8195;* &#8195;&#8195;* </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please sign
and date this Agreement where noted below, and return it to me by September&nbsp;30, 2025, if you wish to accept employment at the Company under the terms described above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We look forward to your favorable reply and to a productive and enjoyable work relationship. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Signature page to follow </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g33819g1002000749355.jpg" ALT="LOGO" STYLE="width:2.02917in;height:0.423611in;">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Aoife Brennan</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Aoife Brennan, CEO</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing correctly sets forth the terms of my <FONT STYLE="white-space:nowrap">at-will</FONT> employment by Climb Bio,
Inc. I am not relying on any representations other than those set forth above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Susan Altschuller</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">September&nbsp;30, 2025</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Susan Altschuller</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">[**]</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attachment: Employee Confidential Information, Inventions Assignment, <FONT STYLE="white-space:nowrap">Non-Competition,</FONT>
and <FONT STYLE="white-space:nowrap">Non-Solicitation</FONT> Agreement </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g33819g1002000749355.jpg" ALT="LOGO" STYLE="width:2.02917in;height:0.423611in;">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>E<SMALL>XHIBIT</SMALL> A </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Definitions </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>&#8220;Accrued Obligations&#8221;</I></B> are (i)&nbsp;your accrued but unpaid salary through the date of termination and, to the extent
consistent with general Company policy, accrued but unused paid time off through and including the date of termination (in each case, paid within the timeframe required by applicable law), (ii) any unreimbursed business expenses incurred by you
payable in accordance with the Company&#8217;s standard expense reimbursement policies, and (iii)&nbsp;benefits owed to you under any qualified retirement plan or health and welfare benefit plan in which you were a participant in accordance with
applicable law and the provisions of such plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Cause</I></B>&#8221; for termination means a good faith determination by the
Board of the occurrence of any one or more of the following: (i)&nbsp;any commission by you of, or plea by you of guilty or nolo contendere to, a felony under applicable law or any crime involving dishonesty or moral turpitude; (ii)&nbsp;your
commission of or participation in (A)&nbsp;a fraud or embezzlement against the Company or its affiliates or (B)&nbsp;an act of dishonesty against the Company or its affiliates that results in (or would reasonably be expected to result in) material
harm to the business or reputation of the Company; (iii)&nbsp;your material violation of any contract or agreement between you and the Company (which shall include, for the avoidance of doubt, your failure to timely sign the Confidential Information
Agreement following the Start Date as required by this Agreement), any statutory or fiduciary duty you owe to the Company under applicable law, or any Company policy; (iv)&nbsp;your willful conduct that constitutes gross misconduct, insubordination,
incompetence or habitual neglect of duties; or (v)&nbsp;your engagement in conduct that results in (or would reasonably be expected to result in) material harm to the business or reputation of the Company; provided, however, that the conduct
described under clause (iii)&nbsp;or (iv) above, if deemed curable by the Board in its reasonable discretion, will only constitute Cause if such conduct is not cured within thirty (30)&nbsp;days after your receipt of written notice from the Company
or the Board specifying the particulars of the conduct that would constitute Cause (which notice, if applicable, need only be provided once during your employment). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Good Reason</I></B>&#8221; shall mean the occurrence of any of the following events without your consent: (i)&nbsp;a material
reduction in your Base Salary or Target Amount, which the parties agree is a reduction of at least ten percent (10%) of your Base Salary or Target Amount as in effect immediately prior to the time such reduction occurs (unless pursuant to a salary
reduction or target bonus reduction program applicable generally to the Company&#8217;s similarly situated executive officers); (ii) a material diminution of your duties, authority or responsibilities <I>provided, however</I>, that the
Company&#8217;s hiring of personnel to handle duties that you were responsible for but which are not regularly associated with your position will not be a &#8220;material diminution&#8221; of your duties, authority or responsibilities; (iii)&nbsp;a
material breach by the Company or any successor entity of this Agreement; or (iv)&nbsp;the relocation of your principal place of employment, without your consent, in a manner that lengthens your <FONT STYLE="white-space:nowrap">one-way</FONT>
commute distance by fifty (50)&nbsp;or more miles from your then-current principal place of employment immediately prior to such relocation; <I>provided, however, </I>that, any such termination by you shall only be deemed for Good Reason pursuant to
this definition if: (1)&nbsp;you give the Company written notice of your intent to terminate for Good Reason within thirty (30)&nbsp;days following the first occurrence of the condition(s) that you believe constitute(s) Good Reason, which notice
shall describe such condition(s); (2) the Company fails to remedy such condition(s) within thirty (30)&nbsp;days following receipt of the written notice (the &#8220;<B><I>Cure Period</I></B>&#8221;); (3) the Company has not, prior to receiving such
notice from you, already informed you that your employment with the Company is being terminated; and (4)&nbsp;you voluntarily terminate your employment within thirty (30)&nbsp;days following the end of the Cure Period. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g33819g1002000749355.jpg" ALT="LOGO" STYLE="width:2.02917in;height:0.423611in;">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>E<SMALL>XHIBIT</SMALL> B </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Change in Control </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Change in Control</I></B>&#8221; means the occurrence, in a single transaction or in a series of related transactions, of any one
or more of the following events: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> any Exchange Act Person becomes the Owner, directly or indirectly, of securities of the
Company representing more than 50% of the combined voting power of the Company&#8217;s then outstanding securities other than by virtue of a merger, consolidation or similar transaction. Notwithstanding the foregoing, a Change in Control will not be
deemed to occur (A)&nbsp;on account of the acquisition of securities of the Company directly from the Company, (B)&nbsp;on account of the acquisition of securities of the Company by an investor, any affiliate thereof or any other Exchange Act Person
that acquires the Company&#8217;s securities in a transaction or series of related transactions the primary purpose of which is to obtain financing for the Company through the issuance of equity securities or (C)&nbsp;solely because the level of
Ownership held by any Exchange Act Person (the &#8220;<B><I>Subject Person</I></B>&#8221;) exceeds the designated percentage threshold of the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the
Company reducing the number of shares outstanding, provided that if a Change in Control would occur (but for the operation of this sentence) as a result of the acquisition of voting securities by the Company, and after such share acquisition, the
Subject Person becomes the Owner of any additional voting securities that, assuming the repurchase or other acquisition had not occurred, increases the percentage of the then outstanding voting securities Owned by the Subject Person over the
designated percentage threshold, then a Change in Control will be deemed to occur; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> there is consummated a merger,
consolidation or similar transaction involving (directly or indirectly) the Company and, immediately after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto do not Own,
directly or indirectly, either (A)&nbsp;outstanding voting securities representing more than 50% of the combined outstanding voting power of the surviving Entity in such merger, consolidation or similar transaction or (B)&nbsp;more than 50% of the
combined outstanding voting power of the parent of the surviving Entity in such merger, consolidation or similar transaction, in each case in substantially the same proportions as their Ownership of the outstanding voting securities of the Company
immediately prior to such transaction; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> there is consummated a sale, lease, exclusive license or other disposition of all or
substantially all of the consolidated assets of the Company and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries to an Entity, more
than 50% of the combined voting power of the voting securities of which are Owned by stockholders of the Company in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such
sale, lease, license or other disposition; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B> the Continuing Directors (as defined below) do not constitute a majority of the
Board (or, if applicable, the Board of a successor corporation to the Company), where the term &#8220;<B>Continuing Director</B>&#8221; means at any date a member of the Board (A)&nbsp;who was a member of the Board on the Effective Date or
(B)&nbsp;who was nominated or elected subsequent to such date by a majority of the directors who were </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g33819g1002000749355.jpg" ALT="LOGO" STYLE="width:2.02917in;height:0.423611in;">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Continuing Directors at the time of such nomination or election or whose election to the Board was recommended or endorsed by a majority of the directors who were Continuing Directors at the time
of such nomination or election; <I>provided, however</I>, that any individual whose initial assumption of office occurred as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or
threatened solicitation of proxies or consents, by or on behalf of a person other than the Board, is excluded from clause (iv)(B) above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding
the foregoing definition, the term Change in Control will not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> For purposes of the definition of Change in Control, the following definitions shall apply: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> &#8220;<B><I>Affiliate</I></B>&#8221; means, at the time of determination, any &#8220;parent&#8221; or &#8220;majority-owned
subsidiary&#8221; of the Company, as such terms are defined in Rule 405. The Board will have the authority to determine the time or times at which &#8220;parent&#8221; or &#8220;majority-owned subsidiary&#8221; status is determined within the
foregoing definition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> &#8220;<B><I>Common Stock</I></B>&#8221; means the common stock of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> &#8220;<B><I>Entity</I></B>&#8221; means a corporation, partnership, limited liability company or other entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B> &#8220;<B><I>Exchange Act Person</I></B>&#8221; means any natural person, Entity or &#8220;group&#8221; (within the meaning of
Section&nbsp;13(d) or 14(d) of the Securities Act of 1933, as amended), except that &#8220;Exchange Act Person&#8221; will not include (i)&nbsp;the Company or any Subsidiary of the Company, (ii)&nbsp;any employee benefit plan of the Company or any
Subsidiary of the Company or any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any Subsidiary of the Company, (iii)&nbsp;an underwriter temporarily holding securities pursuant to a registered public
offering of such securities, (iv)&nbsp;an Entity Owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their Ownership of stock of the Company; or (v)&nbsp;any natural person, Entity or
&#8220;group&#8221; (within the meaning of Section&nbsp;13(d) or 14(d) of the Exchange Act) that, as of the Effective Date, is the Owner, directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of
the Company&#8217;s then outstanding securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(v)</B> &#8220;<B><I>Own</I></B>,&#8221; &#8220;<B><I>Owned</I></B>,&#8221;
&#8220;<B><I>Owner</I></B>,&#8221; &#8220;<B><I>Ownership</I></B>&#8221; A person or Entity will be deemed to &#8220;Own,&#8221; to have &#8220;Owned,&#8221; to be the &#8220;Owner&#8221; of, or to have acquired &#8220;Ownership&#8221; of securities
if such person or Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting, with respect to such securities.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(vi)</B> &#8220;<B><I>Rule 405</I></B>&#8221; means Rule 405 promulgated under the Securities Act of 1933, as amended. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g33819g1002000749355.jpg" ALT="LOGO" STYLE="width:2.02917in;height:0.423611in;">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(vii)</B> &#8220;<B><I>Subsidiary</I></B>&#8221; means, with respect to the Company,
(i)&nbsp;any corporation of which more than 50% of the outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, stock of any other class or
classes of such corporation will have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, Owned by the Company, and (ii)&nbsp;any partnership, limited liability company or other entity in
which the Company has a direct or indirect interest (whether in the form of voting or participation in profits or capital contribution) of more than 50%. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>clym-20250930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2512 Build:20250722.1 -->
<!-- Creation date: 10/2/2025 1:20:49 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2025"
  xmlns:clym="http://climbbio.com/20250930"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://climbbio.com/20250930"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" namespace="http://xbrl.sec.gov/naics/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clym-20250930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clym-20250930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>clym-20250930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2512 Build:20250722.1 -->
<!-- Creation date: 10/2/2025 1:20:49 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>clym-20250930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2512 Build:20250722.1 -->
<!-- Creation date: 10/2/2025 1:20:49 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="clym-20250930.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g33819g1002000749355.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g33819g1002000749355.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  H , # 2(  A$! Q$!_\0
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MC7+%KW3/"UM<VP8KO5SU'48+9[T >LT5PO@;XB#Q5?7.EWM@;'4;=2QCR2&
M.#UY!!(XJ_XC\0:Q9^(M-T31K6REN+R*24O=NRJ O;Y: .KHKA[_ ,4>)_#4
M*7WB#2=/?31(J336$[%H03@,58<C..E=7J=\;'1;R_B59#!;O,H)X;"DB@"[
M169X=U.36O#NGZE+&L<ES LK(O0$CM6#/XIU75M5NM.\*6-M<+9OY=S?7DA6
M%7[JH7EB.] '8T5Q3^*==\.W-NOBNPLUL9Y!&-0L'8QQ,>F]6Y ]Z[7.1D4
M9^IVL-R(_.N%A"9/S$<CC->?>,?B19:':MI?AR2.:\/#W*D,L7T/1F_0?I6]
M\2_#4OB+PPQM4+WEHWG1*!RX_B4?AS]0*^=B""0001US6V$P&'=5XBWO/<PQ
M&(J*/L^A-->W5Q=M=S7$KW#-N,K.2V?7->I^"?B>CQKI/B>3?&>([Q^WL_\
M\5^?K7DM%>G5HPJQY)K0XX5)0?,CZITVTM(YC<6MVDT;K\@1@01]1UKEOC"T
MJ_#ZX$6=K3Q"3']W/^.*S_A!X9FT[39]9NT*27@"PJW41CG/XG'Y>]>@ZIIE
MKK.EW&G7L>^WN$*.._U'N.M>'#"TL+>E16AZ?M9U5S3W.8^%<=FGP^TXVFW+
M[S,1U,FXYS[XQ^&*ZE8K :G)(B6XOVC&]@%\TIGC/?&:\BC^'WCOPK=3)X7U
M='LY&R 7"G_@2L"N?<5T?@CP+K&FZ]-XB\1ZE]IU&2,QJB.6 !Z[C]!P!P*L
M#G/%W_)>-#^MO_Z$:]GKR_QWX"\0:QXOMM>T*ZMHI(HD"F1RK(ZDX(X(/6DT
MG0?BA#JUK)>Z];-:+*IF4N&W)GD8V>GTH B^.G_( TO_ *^C_P"@FNIU7_DD
MUS_V!C_Z*JK\2_".H>+M(L[?3GA66"?>1,Q4$$$=0#6[?:-+<^"YM$21!,]@
M;57/W=VS;GZ9H \%T**7P_H>C^,[2-F-KJ#P72J?O(0N/S!<?B*BUZVFU3PW
M=>,+Q2)]2U3RX0?X8PK9Q^.!_P !KV3P/X,?1_!DFB:[#;7/G3M(\7WTP<8Z
MC_9S47C_ ,$S:[X5L]*T..VMQ:SATB/R(%PP.,#WS0!-K'_)')O^P.O_ *+%
M<+\.'\;+X3<>'X=*:T^T/\UR6W[\#/0XQTKU&]T*6[\#2:")D69K 6HD(^7<
M$VY^F17GN@^%/B5X:TTZ?IEYI4=N9"^&.XY..Y7VH A^&<EO8^/-5L]:AF3Q
M+,TFZ1F!C/.Y@ .A/7OP.U=)XK_M(?$OP\=*6U:[%I<;1=%@F,<YV\]*B\&?
M#W4M,\2S>)/$.H1W6HN&VK%D@,PP220.W  %;'B31];D\4Z5KFC16<[6D,L3
MQ7,I3.[N" : ,+Q<GBB;2\^(K:QDT&)EDO8],D;S652#_&/N@X) P:[#6IX+
MKP1J%Q;,&@ETZ1XR.A4QDC]*PM3T_P :^(]/ETN[32-.L[@;)Y8I'ED*=PH(
M Y]ZZ.ZT@#PI-HUG@#[$UM#O/^QM&: ,WP>9!\-]*,/^M%@I3Z[>*J?"P0_\
M*^T]H\&1VD:8]R^]LY]^E;GAC3I](\,:;IUR4,]M;K&^PY&0.<5S_P#PCVN^
M&M3N[KPPUK<6%Y)YLNG73%/+D/5HV'3/H: -3QXD#^!-:%P 4%JQ&?[PY7\<
MXJWX6:=O"6CM<Y\XV<1?/7.P5SUUH7B/Q;)%!XB%G8:1&ZR/96LAD><@Y 9\
M !?I7;JH50J@!0, #M0 M<)XJ^%^E^(9WO+60V%Z_+LBY1SZE?7W%%%5"<H.
M\63**DK,X=_@MKPEVI?:>R?WBSC]-M=5X;^$.G:9.EUJTXOY4.5B"[8@??NW
MZ#VHHK66)J25KF:H03O8]( "@   #@ 4M%%8&P4444 %%%% !1110 4444 %
6%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001768446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CLIMB BIO, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-2273741<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">20 William Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Wellesley Hills<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02481<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(866)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">857-2596<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CLYM<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d33819d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>clym-20250930.xsd</File>
    <File>clym-20250930_lab.xml</File>
    <File>clym-20250930_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="d33819d8k.htm">d33819d8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d33819d8k.htm": {
   "nsprefix": "clym",
   "nsuri": "http://climbbio.com/20250930",
   "dts": {
    "schema": {
     "local": [
      "clym-20250930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "clym-20250930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "clym-20250930_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d33819d8k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 24
   },
   "report": {
    "R1": {
     "role": "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-09-30_to_2025-09-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d33819d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-09-30_to_2025-09-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d33819d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://climbbio.com//20250930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-25-227025-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-227025-xbrl.zip
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M8;(ZP^U-?]:;JV;7N)^_ 5!+ P04    " #OBD%;!<ZE2J@&  "B20  %0
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MQY7:TG]=*-]%L[^QH_;\#U!+ P04    " #OBD%;DJ<"<]H$  #U+0  %0
M &-L>6TM,C R-3 Y,S!?<')E+GAM;-6:77/B-A2&[W=F_X/JWK0S-<9.TBU,
MR XER0[3? VP;:<W.\(^@*:RY)%,@'_?(X.V&$P6LMN.E8L MMZC]YQ'"$OV
MY?MERLDS*,VDZ'AAH^D1$+%,F)AVO+GVJ8X9\XC.J4@HEP(ZW@JT]_[J[9O+
M[WR?7-_V'XA/9GF>Z780+!:+1C)A0DL^SS&D;L0R#8COV_:]T4?R^[J[-AD
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MNF;.^I0%\$C]P*!2W2*F7 (\W>?J,!S+#8SVE5C*J/<G#+"(/S)DQNQI!/A
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M2_D(#S"1/AW[TUF58HYU8ADPYY<T;^]:>P0+&P87-HZK@[?Y'CB@KX>^E1$
M9\;J*?X (B.((;%JAEBX_V"RT/3 [( ,6#%(A!N-0)%$(^7VC+!4D]H"0$I"
M?>/JP-1 B4@(1%W6V4%"JD-C>HRX.6@B%B[UIP(\\!=Y$">HM> 8Z#,AD'IW
M2>PHFC!OUETDO@T0Y=-O]WKB<P5-ZLK"!+N]/8V1S=+ Q;/*(&_>IHD $85X
M*A%RJR^2W9I9\HA^1?=YHJU1C&YC81+L+A6I(:.N*C=B) ["GNY8;8%D8IE'
M\?K-R.,0'9.+R$%([AA,8F/,K"9)JM-'^UF#G>:E;B[NSA/71;%X7'^$;B!
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MN=Z'0NTMWQPT]^ G1 O;80:8$0P2)?H=T4Z]?F0=.^S1 KLS#&&P?'"SYF;
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M[='_ U!+ 0(4 Q0    ( .^*05L8;WTL. ,  #X+   1              "
M 0    !C;'EM+3(P,C4P.3,P+GAS9%!+ 0(4 Q0    ( .^*05L%SJ5*J 8
M *))   5              "  6<#  !C;'EM+3(P,C4P.3,P7VQA8BYX;6Q0
M2P$"% ,4    " #OBD%;DJ<"<]H$  #U+0  %0              @ %""@
M8VQY;2TR,#(U,#DS,%]P<F4N>&UL4$L! A0#%     @ [XI!6Y5S)P2)&0
MVXX   T              ( !3P\  &0S,S@Q.60X:RYH=&U02P$"% ,4
M" #OBD%;5"9G,80T  !'[0  $               @ $#*0  9#,S.#$Y9&5X
=,3 Q+FAT;5!+!08     !0 % #X!  "U70     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>d33819d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="clym-20250930.xsd" xlink:type="simple"/>
    <context id="duration_2025-09-30_to_2025-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001768446</identifier>
        </entity>
        <period>
            <startDate>2025-09-30</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-290">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-09-30_to_2025-09-30"
      id="Hidden_dei_EntityCentralIndexKey">0001768446</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-301">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-302">2025-09-30</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-303">CLIMB BIO, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-304">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-305">001-40708</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-306">83-2273741</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-307">20 William Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-308">Suite 145</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-309">Wellesley Hills</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-310">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-311">02481</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-312">(866)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-313">857-2596</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-314">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-315">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-316">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-317">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-318">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-319">CLYM</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-320">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-321">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2025-09-30_to_2025-09-30" id="ixv-322">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
